NDC product
Orostat 8%
NDC 10129-006 · Gingi-Pak a Division of the Belport
Key facts
| Product NDC | 10129-006 |
|---|---|
| Proprietary name | Orostat 8% |
| Nonproprietary name | EPINEPHRINE HYDROCHLORIDE |
| Substances | EPINEPHRINE HYDROCHLORIDE |
| Dosage form | SOLUTION |
| Route | DENTAL, PERIODONTAL, SUBGINGIVAL |
| Labeler | Gingi-Pak a Division of the Belport |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] |
| Marketing start | Apr 4, 1990 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: